First Manhattan’s Applied Therapeutics APLT Stock Holding History

First Manhattan’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-73,783	Closed	-$68K	–	1688
2022 Q3	$68K	Hold	73,783	–	–	﹤0.01%	883
2022 Q2	$69K	Hold	73,783	–	–	﹤0.01%	921
2022 Q1	$155K	Hold	73,783	–	–	﹤0.01%	805
2021 Q4	$660K	Hold	73,783	–	–	﹤0.01%	511
2021 Q3	$1.22M	Hold	73,783	–	–	﹤0.01%	402
2021 Q2	$1.53M	Buy	+73,783	New	+$1.4M	0.01%	369

Other funds holding APLT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

First Manhattan's APLT Position: Q4 2022 in Review

First Manhattan sold out of Applied Therapeutics (APLT) in Q4 2022, closing a stake of 73,783 shares — an estimated $68K sold.

First Manhattan first reported a position in APLT in Q2 2021 and held it in 6 quarters. The position peaked at $1.53M in Q2 2021. 38 funds tracked by Wall St. Rank hold APLT as of Q4 2022.

First Manhattan reported no remaining Applied Therapeutics position as of Q4 2022 after selling out during the quarter.
First Manhattan sold 73,783 Applied Therapeutics shares in Q4 2022, an estimated $68K.
First Manhattan first reported a position in Applied Therapeutics in Q2 2021 and held it in 6 quarters.
First Manhattan's Applied Therapeutics position peaked at $1.53M in Q2 2021.
38 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.